Year: 2023
Type: article
Source: Tuberculosis
Institutions: University of Cape Town, The Francis Crick Institute, Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Imperial College London, London School of Hygiene & Tropical Medicine, University of Oxford, Oxford University Clinical Research Unit, Radboud University Nijmegen, Radboud University Medical Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Wellcome Trust, Francis Crick Institute, Meningitis Now, Cancer Research UK, National Institute for Health and Care Research, National Institutes of Health, Medical Research Council, National Institute of Allergy and Infectious Diseases, Fogarty International Center, European and Developing Countries Clinical Trials Partnership
Awards: G2153719109, Randomised Controlled Trial of Preventive Treatment of Latent Tuberculosis Infection in Patients with Diabetes Mellitus, G3742195148, G3765344608, G4758841269, G4998888567, G5131331932, G5134614249, G54722676, Centre for Infectious Diseases Research in Africa (CIDRI-Africa), G6127614566, G6301998524, G7123709860, G7710374980, G8621900669, G9000075691, G9000145151, G9000227143
OpenAlex ID: W4382700928